BioScience Trends, published by IRCA-BSSA, is a leading academic journal based in Japan that significantly contributes to the fields of biochemistry, genetics, molecular biology, and social health sciences. With an impactful Scopus ranking that places it in the 97th percentile for health social sciences and the 89th percentile for general biochemistry, this journal is an essential resource for researchers and professionals alike. Since its inception in 2007, BioScience Trends has fostered high-quality research dissemination and collaboration, offering a platform for innovative studies and insights that are vital for advancing knowledge in life sciences. Despite being a non-open access publication, it maintains rigorous standards and a reputable presence in the academic community, with an impressive categorization into Q1 and Q2 quartiles as of 2023. Researchers, students, and professionals seeking to stay at the forefront of scientific exploration and health advancements will find BioScience Trends to be an invaluable source for scholarly articles and emerging trends in their respective fields.

BMC Research Notes, published by SPRINGERNATURE, is a leading open-access journal dedicated to the dissemination of research notes across various disciplines, particularly within the fields of biochemistry, genetics, molecular biology, and medicine. Since its establishment in 2008, the journal has embraced a mission to facilitate the rapid publication of short, concise articles that contribute significantly to ongoing scientific dialogues. With an impact factor reflective of its reputation, BMC Research Notes ranks Q2 in Biochemistry, Genetics and Molecular Biology and holds a commendable Q3 classification in Medicine for 2023. Notably, the journal's Scopus rankings highlight its prominence, especially in General Medicine, where it stands in the 77th percentile. Situated in the United Kingdom, the journal prioritizes open access to foster transparency and engagement with a global audience, making it an essential resource for researchers, practitioners, and students who are looking to stay abreast of new findings and practical advancements within their fields. The journal continues to span evolving research themes from 2008 to 2024, ensuring a dynamic repository of knowledge in the rapidly advancing landscape of biomedical research.

Journal of Preventive Medicine & Public Health is a premier peer-reviewed open-access journal published by the Korean Society for Preventive Medicine, dedicated to advancing the fields of preventive medicine and public health. Established in 1968, this journal has carved out a significant niche in the academic community, reflected in its prestigious Q1 ranking in both Medicine (miscellaneous) and Public Health, Environmental, and Occupational Health as of 2023. With a focus on disseminating high-quality research, the journal serves as an essential platform for researchers, professionals, and students to share innovative findings and discuss contemporary challenges in health prevention strategies. The journal maintains a strong commitment to accessibility, offering open access to its content since inception, ensuring that critical research is readily available to the global community. The Journal of Preventive Medicine & Public Health not only contributes to the scientific discourse but also plays a pivotal role in shaping public health policies, making it an invaluable resource for anyone invested in the health sciences.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

Gazi Medical Journal, an esteemed publication by GALENOS PUBL HOUSE, is a prominent platform in the field of medicine, dedicated to the dissemination of innovative research and critical reviews in diverse medical disciplines. Established in 1992 and transitioning to an Open Access model in 2005, this journal aims to promote unrestricted access to valuable medical knowledge, enhancing the reach and impact of research contributions. With a growing presence in the academic community, it currently holds a Q4 quartile ranking in the category of Medicine (miscellaneous) for 2023, and it ranks at #528 out of 636 in the realm of General Medicine on Scopus, representing the 16th percentile. The journal covers a wide array of topics, making it a vital resource for researchers, healthcare professionals, and students eager to stay informed about the latest medical advancements and practices. Located in the heart of Istanbul, Turkey, Gazi Medical Journal welcomes submissions that inspire thought, spark innovation, and contribute to the ongoing discourse in the medical field.

The American Journal of Translational Research is a pivotal publication in the fields of Biochemistry, Genetics, and Molecular Biology, dedicated to advancing the understanding of translational science and its applications in clinical settings. Published by E-CENTURY PUBLISHING CORP, this journal, under ISSN 1943-8141, fosters scholarly exchange by publishing original research articles, reviews, and clinical studies that bridge the gap between laboratory discoveries and actual medical practice. Although its coverage in Scopus has been discontinued, the journal has previously held respectable rankings, including a 64th percentile in Clinical Biochemistry and 52nd in both Molecular Medicine and Cancer Research, indicating its influence and relevance in the scientific community. With its formal objective of disseminating significant findings that inform clinical practices, the journal remains a valuable resource for researchers, healthcare professionals, and students eager to stay at the forefront of translational research advancements.

Archives of Medical Research is a prestigious scholarly journal dedicated to advancing the field of medicine through the dissemination of high-quality research findings. Published by Elsevier Science Inc., this esteemed journal has garnered significant recognition, boasting a remarkable impact factor and ranking in the top quartile (Q1) of its category, specifically in General Medicine with a Scopus rank of #30 out of 636 journals, placing it in the 95th percentile. Since its inception in 1992, Archives of Medical Research has served as a critical platform for researchers and professionals to share innovative insights and empirical studies that address pressing medical issues and enhance clinical practices. The journal welcomes a range of submissions, ensuring a diverse array of topics that reflect the latest trends and developments in medicine. As the journal continues to push the boundaries of medical research until at least 2025, it remains an essential resource for students, academics, and healthcare professionals striving to make a meaningful impact in the medical community.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

LIFE SCIENCES, published by PERGAMON-ELSEVIER SCIENCE LTD, is an esteemed international journal that has been advancing the field since its inception in 1962. With an ISSN of 0024-3205 and an E-ISSN of 1879-0631, it serves as a critical forum for researchers, professionals, and students within the realms of biochemistry, genetics, molecular biology, medicine, and pharmacology. Currently ranked in the Q1 category across multiple disciplines, including a remarkable 2nd rank in General Pharmacology, Toxicology, and Pharmaceutics, the journal maintains a prestigious position in academic circles, evidenced by its high impact factor and significant percentile ranks. While LIFE SCIENCES is not an open-access journal, it remains dedicated to publishing high-quality, peer-reviewed research that pushes the boundaries of knowledge and fosters innovation. With converged research interests leading into 2024, LIFE SCIENCES continues to be a pivotal resource for the dissemination of influential findings, making it an indispensable tool for those engaged in the life sciences.